Engel B, Diestelhorst J, Hupa-Breier K, Kirchner T, Henjes N, Loges S
Hepatol Int. 2024; 18(4):1214-1226.
PMID: 38976227
PMC: 11297808.
DOI: 10.1007/s12072-024-10695-1.
Rizzetto M
Clin Liver Dis (Hoboken). 2020; 16(Suppl 1):1-11.
PMID: 33042522
PMC: 7538916.
DOI: 10.1002/cld.1033.
Ziemnicka K, Gut P, Golab M, Dworacki G, Wrotkowska E, Stajgis M
Arch Immunol Ther Exp (Warsz). 2016; 64(6):485-495.
PMID: 26970862
PMC: 5085985.
DOI: 10.1007/s00005-016-0386-x.
Liberal R, Vergani D, Mieli-Vergani G
J Clin Transl Hepatol. 2015; 3(1):42-52.
PMID: 26357634
PMC: 4542083.
DOI: 10.14218/JCTH.2014.00032.
Himoto T, Nishioka M
Auto Immun Highlights. 2015; 4(2):39-53.
PMID: 26000142
PMC: 4389052.
DOI: 10.1007/s13317-013-0046-7.
Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory.
Tozzoli R, Antico A, Porcelli B, Bassetti D
Auto Immun Highlights. 2015; 3(2):59-65.
PMID: 26000128
PMC: 4389066.
DOI: 10.1007/s13317-012-0035-2.
Epidemiology and treatment of autoimmune hepatitis.
Francque S, Vonghia L, Ramon A, Michielsen P
Hepat Med. 2013; 4:1-10.
PMID: 24367228
PMC: 3846915.
DOI: 10.2147/HMER.S16321.
Cutting edge issues in autoimmune hepatitis.
Vergani D, Mieli-Vergani G
Clin Rev Allergy Immunol. 2011; 42(3):309-21.
PMID: 21207191
DOI: 10.1007/s12016-010-8236-9.
A 50-year experience with autoimmune hepatitis: and where are we now?.
Mackay I
J Gastroenterol. 2010; 46 Suppl 1:17-28.
PMID: 21072544
DOI: 10.1007/s00535-010-0325-2.
Autoimmune hepatitis.
Vergani D, Longhi M, Bogdanos D, Ma Y, Mieli-Vergani G
Semin Immunopathol. 2009; 31(3):421-35.
PMID: 19533129
DOI: 10.1007/s00281-009-0170-7.
Paraproteins with antibody activity in acute viral hepatitis and chronic autoimmune liver diseases.
Roux M, Florin-Christensen A, Arana R, Doniach D
Gut. 1974; 15(5):396-400.
PMID: 18668850
PMC: 1412926.
DOI: 10.1136/gut.15.5.396.
Autoimmune liver serology: current diagnostic and clinical challenges.
Bogdanos D, Invernizzi P, Mackay I, Vergani D
World J Gastroenterol. 2008; 14(21):3374-87.
PMID: 18528935
PMC: 2716592.
DOI: 10.3748/wjg.14.3374.
Historical reflections on autoimmune hepatitis.
Mackay I
World J Gastroenterol. 2008; 14(21):3292-300.
PMID: 18528926
PMC: 2716583.
DOI: 10.3748/wjg.14.3292.
Serum mannan-binding lectin levels in patients with celiac disease: an analysis of clinical and autoimmune features.
Grangeiro de Carvalho E, Ramos da Rosa Utiyama S, Kotze L, Taborda de Messias Reason I
Dig Dis Sci. 2007; 52(9):2145-51.
PMID: 17393323
DOI: 10.1007/s10620-007-9792-6.
Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K, Rigopoulou E, Dalekos G
J Autoimmune Dis. 2005; 1(1):2.
PMID: 15679907
PMC: 544946.
DOI: 10.1186/1740-2557-1-2.
Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays.
Kerkar N, Ma Y, Davies E, Cheeseman P, Mieli-Vergani G, Vergani D
J Clin Pathol. 2002; 55(12):906-9.
PMID: 12461054
PMC: 1769836.
DOI: 10.1136/jcp.55.12.906.
Spectrum of autoantibodies in celiac patients and relatives.
da Rosa Utiyama S, da Silva Kotze L, Nisihara R, Carvalho R, de Carvalho E, de Sena M
Dig Dis Sci. 2002; 46(12):2624-30.
PMID: 11768251
DOI: 10.1023/a:1012702807714.
Autoantibodies in recent onset type-1 diabetic patients to a Mr 60K microsomal hepatic protein: new evidence for autoantibodies to the type-2 glucose transporter.
Alvarez F, Bach J, Chatenoud L
Clin Exp Immunol. 2000; 122(2):164-9.
PMID: 11091270
PMC: 1905770.
DOI: 10.1046/j.1365-2249.2000.01366.x.
Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.
Boitier E, Beaune P
Clin Rev Allergy Immunol. 2000; 18(2):215-39.
PMID: 10944706
DOI: 10.1385/CRIAI:18:2:215.
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
Muratori L, Parola M, Ripalti A, ROBINO G, Muratori P, Bellomo G
Gut. 2000; 46(4):553-61.
PMID: 10716687
PMC: 1727874.
DOI: 10.1136/gut.46.4.553.